{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Repigment, Reframe, Restore: JAK Inhibition A New Era for Vitiligo \ud83c\udfaf","description":"\ud83c\udfa8 Repigment, Reframe, Restore: A New Era for Vitiligo Vitiligo is far more than a cosmetic condition. In two phase 3 Viti-Up trials, oral upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48 weeks. \ud83d\udc8a But here is the deeper lesson: better pigmentation \u2260 complete patient benefit. Only 13\u201315% reported their vitiligo as \u201ca lot less\u201d or \u201cno longer\u201d noticeable. \ud83d\udc41\ufe0f The future of vitiligo care must measure not only pigment, but also dignity, mental health, long-term safety and access. \ud83e\udde0\u2764\ufe0f #Vitiligo #Dermatology #JAKInhibitors #MedicalPodcasts ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/42482715\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/205224575"}